Publication:
A phase II pilot study of weekly docetaxel cisplatin and 5-fluorouracil in metastatic gastric cancer.

dc.contributor.authorDANE, FAYSAL
dc.contributor.authorsOkutur, K.; Dane, F.; Ilhan, M.; Seber, S.; Korkmaz, T.; Aydin, K.; Bozkurt, M.; Namal, E.; Turhal, N. S.; Demir, G.
dc.date.accessioned2022-03-10T17:50:11Z
dc.date.accessioned2026-01-11T11:00:22Z
dc.date.available2022-03-10T17:50:11Z
dc.date.issued2010
dc.identifier.doi10.1200/jco.2010.28.15_suppl.e14589
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221294
dc.identifier.wosWOS:000208852000714
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleA phase II pilot study of weekly docetaxel cisplatin and 5-fluorouracil in metastatic gastric cancer.
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume28

Files